Psoriasis patients who use biologics are protected against severe COVID-19

COVID-19 outcomes are better in people with psoriasis who use biologic therapy rather than non-biologic therapy to manage their skin condition, research shows. International data from the Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 infecTion (PsoProtect) and the self-reporting patient-facing registry PsoProtectMe was supplemented by cases from two US registries SECURE-Psoriasis and ...

Already a member?

Login to keep reading.

© 2021 the limbic